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progressive exertional dyspnea was admitted to our
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(A) Cardiac computed tomographic angiography (CTA) showing the con
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e84ejection fraction was 64%. Bicuspidy of the aortic valve and
aneurysmal dilation of the ascending aorta (56 mm in
diameter) were noted on TTE. She was declined for surgery
on account of high operative risk (logistic EuroSCORE
31.67%) after consultations by the heart team, thus she
was evaluated for transcatheter aortic valve implantation
(TAVI). Coronary angiogram showed the absence of sig-
niﬁcant coronary lesions. Three-dimensional computed
tomographic angiography (CTA) conﬁrmed the bicuspidy
(Fig. 1A) and measured the diameter of the ascending
aorta at 53 mm (Fig. 1B); the annulus was elliptical with
a long-axis diameter of 25.6 mm and a short-axis diameter
of 19.5 mm. TAVI was conducted in a hybrid operating
room, with the patient under general anesthesia. After
aortic valvuloplasty with a 22-mm balloon, a 29-mm self-
expandable Medtronic CoreValve (Medtronic, Minneap-
olis, Minnesota) was successfully deployed via the right
transfemoral approach (Fig. 1C). The immediate post-
deployment aortography and transesophageal echocardi-
ography showed moderate periprosthetic regurgitation.
Hence, post-dilation was performed with a 26-mm balloon;
thereafter, only mild regurgitation was noted. Post-TAVI
mean gradient decreased strikingly to 9 mm Hg, and peak
velocity to 2.1 m/s. Post-operative recovery was uneventful,
and she was discharged with a well-functioning prosthetic
aortic valve and in good general condition 2 weeks after
TAVI. Pre-discharge CTA is shown in Figures 1D to 1F.
A bicuspid aortic valve (BAV) is frequently associated
with dilation of the proximal aorta, especially in the presence
of AR and/or AS (1). Although TAVI has shown its feasi-
bility and safety in selected high-risk patients with BAV
stenosis (2), the coexistence of an ascending aortic aneurysm
would render surgery mandatory in order to be able toaddress both lesions simultaneously and to avoid catastrophic
stent-related complications (e.g., prosthesis dislodgment
and aneurysm rupture). In fact, a previous attempt of
transapical TAVI in a patient with concomitant BAV ste-
nosis and ascending aortic aneurysm resulted in progressive
prosthesis dislocation requiring open-heart surgery (3).
Despite the achieved success in the present case, it is a serious
concern as to the fate of the untreated aneurysm, which is
exposed to the radial force of the stent frame. Therefore,
TAVI for such patients should only be considered on the
premise of contraindication to surgery or excessive operative
risk that outweighs the anticipated beneﬁts.
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